Tandem Diabetes Care, Inc. (TNDM) Financial Statements
Tandem Diabetes Care, Inc. (TNDM) reported trailing twelve-month revenue of $1.0B (up 4.0% year on year) and net income of -$63.3M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$26.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TNDMTandem Diabetes Care, Inc.Follow TNDM — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.05 | 0.07 | 0.08 | 0.11 | 0.18 | 0.36 | 0.50 | 0.70 | 0.80 | 0.75 | 0.94 | 1.01 | 1.04 | |
| Gross profit | 0.02 | 0.03 | 0.02 | 0.04 | 0.09 | 0.19 | 0.26 | 0.38 | 0.41 | 0.37 | 0.49 | 0.55 | 0.58 | |
| Research & development | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.05 | 0.06 | 0.09 | 0.14 | 0.17 | 0.20 | 0.19 | 0.19 | |
| Operating income | -0.08 | -0.07 | -0.08 | -0.06 | -0.04 | -0.02 | -0.01 | 0.02 | -0.09 | -0.23 | -0.10 | -0.19 | -0.05 | |
| Pre-tax income | -0.08 | -0.07 | -0.08 | -0.07 | -0.12 | -0.02 | -0.04 | 0.02 | -0.09 | -0.22 | -0.09 | -0.20 | -0.06 | |
| Income tax | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net income | -0.08 | -0.07 | -0.08 | -0.07 | -0.12 | -0.02 | -0.03 | 0.02 | -0.09 | -0.22 | -0.10 | -0.20 | -0.06 | |
| Diluted EPS ($) | -3.42 | -25.04 | -27.30 | -12.87 | -2.55 | -0.42 | -0.56 | 0.24 | -1.47 | -3.43 | -1.47 | -3.04 | -0.93 | |
| Diluted shares (bn) | — | — | — | — | — | — | — | 0.064 | 0.064 | 0.065 | 0.065 | 0.067 | — |
USD billions · SEC XBRL
Tandem Diabetes Care, Inc. — questions
- What is Tandem Diabetes Care, Inc.'s revenue?
- $1.0B over the twelve months to 2026-06-30, up 4.0% year on year, from its 10-Q and 10-K filings.
- What is Tandem Diabetes Care, Inc.'s net income?
- -$63.3M over the twelve months to 2026-06-30.
- What is Tandem Diabetes Care, Inc.'s free cash flow?
- -$26.6M over the twelve months to 2026-06-30.
- What are Tandem Diabetes Care, Inc.'s diluted earnings per share?
- $-0.93 over the twelve months to 2026-06-30.
Every figure on this page comes from Tandem Diabetes Care, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.